New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications ...
CANTON, Mass.--(BUSINESS WIRE)--Abveris, Inc., a leader in contract research antibody discovery, today announced the deployment of the Berkeley Lights, Inc. Beacon® optofluidic platform for antibody ...
EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and ...
Fargo, N.D., June 11, 2019 (GLOBE NEWSWIRE) -- Aldevron, a global leader in antibody discovery to the biotech industry, announced today the acquisition and installation of the Beacon Optofluidic ...
EMERYVILLE, Calif. and MELBOURNE, Australia, Nov. 9, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, today announced Monash University, one of Australia's leading ...
EMERYVILLE, Calif., Nov. 30, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & ...
EMERYVILLE, Calif., Dec. 5, 2018 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today the release of a plasma B cell antibody discovery workflow for use on ...
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CDMO), today announced Curia’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results